Current Report · Items 4.02 · 8-K
CS Diagnostics Corp.
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report
Item 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review. On June 23, 2026, the Board of Directors (the "Board") of CS Diagnostics Corp.…
Company context
Current securities
Historical securities (6)
CITCOTC · EQUITY · Historical · closed Mar 11, 2015CITCDOTC · EQUITY · Historical · closed Apr 9, 2015CSDXOTC · EQUITY · Historical · closed Oct 19, 2026FZROOTC · EQUITY · Historical · closed Aug 3, 2023FZROOTC · EQUITY · Historical · closed Aug 3, 2023FZRODOTC · EQUITY · Historical · closed Aug 30, 2023
Disclosure sections
Item 4.02Item 4.02 - Non-Reliance on Financial Statements
Item 4.02 Non-Reliance on Previously Issued Financial Statements
or a Related Audit Report or Completed Interim Review.
On June 23, 2026, the Board of Directors (the "Board") of
CS Diagnostics Corp. (the "Company"), after reviewing the findings of management and considering information presented regarding
the Company's historical accounting, financial reporting, audit history, and disclosure controls, determined that the Company's previously
issued financial statements for the fiscal years ended December 31, 2022, December 31, 2023, December 31, 2024, and December 31, 2025,
and any interim financial statements or other financial information included in filings or reports for periods affected by the matters
described below (collectively, the "Affected Financial Statements"), should no longer be relied upon.
In connection with this determination, the Board directed management
to promptly undertake all necessary actions to correct and restate the Affected Financial Statements. The Board further authorized and
instructed management to engage KBF Advisory LLC ("KBF"), the Company's technical accounting advisor, and Shah Teelani &
Associates LLC ("Shah Teelani"), the Company's independent registered public accounting firm, to assist in reviewing the Company's
accounting treatment, conducting the required re-audits and analyses, and preparing and refiling the Affected Financial Statements and
related reports with the Securities and Exchange Commission as expeditiously as practicable.
The Board reached this conclusion in connection with communications
with the Staff of the Division of Corporation Finance of the Securities and Exchange Commission regarding the Company's registration statement
and management's subsequent review of the Company's historical accounting, financial reporting, audit history and disclosure controls.
The matters giving rise to the non-reliance determination include the
following:
(i) Approximately $499.4 million intangible asset.
Management has preliminarily concluded that the approximately $499.4
million intangible asset recorded in connection with a September 4, 2023 transaction was improperly recognized and should be removed from
the Company's balance sheet. Management has reassessed the transaction and now believes that the transaction should be evaluated under
ASC 805-50, Transactions Between Entities Under Common Control, rather than under a fair value acquisition model. Management is also evaluating
the application of ASC 730, Research and Development, ASC 350, Intangibles - Goodwill and Other, ASC 820, Fair Value Measurement, and
related U.S. GAAP guidance.
The Company has engaged KBF to assist management in evaluating the
appropriate accounting treatment of the transaction, the accounting periods affected, the impact on previously issued financial statements
and the disclosures and corrective actions required under U.S. GAAP and SEC rules. KBF is acting as a technical accounting advisor and
is not engaged to provide audit or attest services. The Company has also engaged Shah Teelani to work with management and KBF in reviewing
the Affected Financial Statements and determining the nature and extent of any required amendments, re-audits, restatements or enhanced
disclosures.
Based on management's preliminary conclusions, the Company currently
expects that removal of the approximately $499.4 million intangible asset will require restatement of the Affected Financial Statements
for one or more reporting periods. The restatement is expected to materially reduce the Company's previously reported total assets and
stockholders' equity and may affect related disclosures, accumulated deficit, internal control conclusions and other financial statement
line items.
(ii) Prior audit reports and auditor-related matters.
The Company is also reviewing its historical auditor engagements and
previously issued audit reports, including audit reports issued by Olayinka Oyebola & Co. ("Olayinka") for certain historical
periods. The Company has been informed that Olayinka is subject to SEC and related regulatory restrictions, including restrictions affecting
reliance on audit reports issued by that firm. As a result, the Company has determined that audit reports issued by Olayinka with respect
to affected historical financial statements, and any financial statements or filings that relied upon such audit reports, should no longer
be relied upon.
The Company previously engaged LAO Professionals as a replacement PCAOB-registered
auditor for certain periods and has subsequently engaged Shah Teelani as its current independent registered public accounting firm. Shah
Teelani is expected to perform audit or re-audit procedures for affected periods, including the fiscal year ended December 31, 2025, as
necessary in connection with the Company's restatement and remediation process.
(iii) Company`s Next Steps.
The Company has taken the following steps to address
these matters and restore the integrity of its financial reporting:
Engaged Shah Teelani & Associates as its new independent registered public accounting firm to re-audit
the affected periods and audit the fiscal year ended December 31, 2025;
──────────────────────────────────────────────────────────────────────────────────────────────────────────
Retained a technical accountant KBF Advisory LLC, to assist in evaluating the accounting treatment of
the $499.4M Intangible and related matters;
Initiated a comprehensive review of the Company's internal controls over financial reporting with the
objective of identifying and remediating the control deficiencies that contributed to the misstatement; and
Committed to convening an annual shareholder meeting at the earliest practicable date, at which management
will provide shareholders with a detailed update on the restatement process, remediation efforts, and the Company's path forward.
The Company is committed to completing the restatement
process as promptly as possible and to providing timely updates to its shareholders and the investing public. The Company currently anticipates
filing restated financial statements for the affected periods, together with its Annual Report on Form 10-K for the fiscal year ended
December 31, 2025, as expeditiously as practicable.
(iv) Shareholders communication.
The Board and management recognize the importance
of transparent and timely communication with the Company's shareholders during this process. The Company wishes to assure its shareholders
that the steps described above reflect management's commitment to accurate financial reporting and sound corporate governance. The identification
of these issues, while significant, represents an important step in building a stronger and more reliable financial reporting infrastructure
for CSDX. The Company has a defined plan, engaged the appropriate professionals, and is moving forward with urgency and purpose.
Shareholders are encouraged to contact the Company
at csdxboard@csdcorp.us with any questions. Additional information will be provided at the annual
shareholder meeting, which the Company expects to schedule in the near term.
Cautionary Note Regarding Forward-Looking Statements
This Current Report on Form 8-K contains forward-looking statements
within the meaning of the federal securities laws, including statements regarding the Company's expectations concerning the removal of
the intangible asset, the anticipated restatement of previously issued financial statements, audit and re-audit procedures, the timing
of amended filings, internal control remediation and related matters. Forward-looking statements are based on current expectations and
assumptions and are subject to risks and uncertainties that could cause actual results, timing or outcomes to differ materially from those
expressed or implied. The Company undertakes no obligation to update forward-looking statements except as required by law.